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Abstract
The effect of various Pasteurella multocida fractions on bovine polymorphonuclear leukocyte (PMN)
functions was examined in vitro by using two encapsulated strains, P-2383 and P-1062 (both are Carter
capsular type A and of bovine origin). The ability of PMNs to ingest Staphylococcus aureus and iodinate
protein was significantly inhibited in the presence of live cells, heat-killed whole cells, or saline-extracted
capsules but not in the presence of the decapsulated heat-killed cells. None of the fractions of the two strains
inhibited nitroblue tetrazolium reduction by PMNs. The saline extract did not inhibit the binding of iodine to
protein by a reaction involving xanthine, xanthine oxidase, and horseradish peroxidase. The PMN inhibitory
factor was further characterized as a heat-stable capsular material of greater than 300,000 molecular weight.
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The effect of various Pasteurella multocida fractions on bovine polymorphonuclear leukocyte (PMN)
functions was examined in vitro by using two encapsulated strains, P-2383 and P-1062 (both are Carter
capsular type A and of bovine origin). The ability of PMNs to ingest Staphylococcus aiureus and iodinate
protein was significantly inhibited in the presence of live cells, heat-killed whole cells, or saline-extracted
capsules but not in the presence of the decapsulated heat-killed cells. None of the fractions of the two
strains inhibited nitroblue tetrazolium reduction by PMNs. The saline extract did not inhibit the binding of
iodine to protein by a reaction involving xanthine, xanthine oxidase, and horseradish peroxidase. The PMN
inhibitory factor was further characterized as a heat-stable capsular material of greater than 300,000
molecular weight.
Pasteurella multocida is a major etiological agent in
bovine respiratory disease (3, 6), with capsular type A
strains being most frequently isolated in North America.
Some encapsulated strains of P. multocida are known to be
highly pathogenic in experimental animals, and the presence
of the mucoid capsule is important for virulence (3, 7). The
capsule of type A strains is primarily composed of hyaluron-
ic acid (4, 5), which serves as a framework for the attach-
ment of polysaccharides, proteins, and lipids (3).
The importance of pasteurellae in bovine respiratory dis-
ease has led to the development and use of various bacterial
products for immunization. The efficacy and safety of most
of these products still remain in question (2, 13, 17, 19).
There is evidence that the use of bacterins that are currently
available may, in fact, be detrimental to the health of the
animal (2, 19).
Recent studies on type A P. multocida capsular materials
indicated that a KSCN extract (12, 20) and a saline extract
(16, 25) were protective against experimental challenge in
mice, chickens, and turkeys. The capsule of a type A P.
multocida has also been demonstrated to inhibit the phago-
cytic activity of bovine neutrophils (18). Therefore, the
capsule may contain not only a protective antigen but also a
component which interferes with phagocytic cell function. It
is not unusual for bacterial surface material to contain both a
protective antigen and a virulence factor (8, 9, 14).
Phagocytosis of invading microorganisms by polymorpho-
nuclear leukocytes (PMNs) can be one of the major cellular
defense mechanisms in protecting animals from microbial
infection. Maheswaran and Thies (18) reported that an
encapsulated type A P. multocida (NA77) inhibited the
phagocytic activity of neutrophils (PMNS). When they mea-
sured the uptake of [3H]thymidine-labeled bacteria by
PMNs, only 3.8% of the encapsulated organisms were
ingested. When the encapsulated bacteria were treated with
bovine testicular hyaluronidase, however, 90% of the decap-
sulated organisms were ingested. They concluded that the
factor which inhibited the phagocytic activity of PMNs was
probably hyaluronic acid, which is a major component of the
capsule of type A P. multocida.
* Corresponding author.
The purpose of the present experiment was to further
characterize an inhibitory factor present in type A P. multo-
cida capsule and determine its effects on specific aspects of
PMN function.
MATERIALS AND METHODS
Organisms. Two strains of P. multocida were used
throughout this study (P-2383 and P-1062). Strain P-2383 was
isolated from a case of bovine pneumonia presented to the
Veterinary Diagnostic Laboratory, Iowa State University,
Ames, Iowa. This isolate was a typical P. multocida strain;
subsequent typing confirmed it to be Carter capsular type A.
Strain P-1062, also a type A strain of bovine origin, is a
challenge strain (IRP-198, National Veterinary Services
Laboratory, U.S. Department of Agriculture, Ames, Iowa).
Each strain was inoculated into the yolk sac of 6-day-old
embryonated chicken eggs. After incubation at 37°C for 18 h,
the yolk material was aseptically removed and frozen in
aliquots at -70°C. These aliquots were used as inoculum for
preparation of bacterial fractions used in this study.
Bacterial fractions. The preparation of bacterial fractions
is illustrated in Fig. 1. Infected yolk material was thawed,
inoculated on a 5% bovine blood agar plate and incubated at
37°C for 24 h. One colony was transferred to 5 ml of brain
heart infusion (BHI) broth (Difco Laboratories, Detroit,
Mich.) containing 0.5% yeast extract (Difco) and 5% sterile
bovine serum (BHISY) and incubated at 37°C for 4 h. This
culture was then added to 100 ml of BHISY and incubated an
additional 4 h. Roux bottles containing dextrose-starch agar
(Difco) were inoculated with 2.0 ml of BHISY culture and
incubated at 37°C for 36 h. Cells were harvested by washing
the agar surface with sterile phosphate-buffered saline solu-
tion (PBS, pH. 7.2), and cell concentration was adjusted so
that a 10-fold dilution had an optical density (OD) of 0.4 at
540 nm (approximately 1010 cells per ml). The cells were
washed three times in PBS, and an aliquot was saved for the
live-cell fraction (LCF). The remaining cells were washed
one more time in PBS. Cells packed by centrifugation were
suspended to the original volume in 2.5% (wt/vol) sodium
chloride solution and placed in a water bath at 56°C for 1 h.
After this saline extraction, an aliquot was saved for the
preparation of a heat-killed whole-cell fraction (KCF). The
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i FIG. 1. Preparation of bacterial fractions.
remainder was centrifuged at 17,300 x g for 20 min at 4°C.
The supernatant was saved, and the pelleted cells were
washed three times and suspended with an equal volume of
sterile PBS. This preparation was designated the decapsulat-
ed heat-killed cell fraction (DCF). The KCF and supernatant
fraction were dialyzed against PBS for 3 days to remove
excess salt and used as the KCF and saline extract fraction
(SEF) (1.06 mg [dry weight]/ml for strain P-2383 and 0.91
mg/ml for strain P-1062). Aliquots of SEF were treated in
various ways including: (i) treatment with bovine testicular
hyaluronidase (Sigma Chemical Co., St. Louis, Mo.; 1 mg of
hyaluronidase per mg [dry weight] of SEF) by incubating in a
water bath at 37°C for 3 h (SEF-H); (ii) autoclaving at 121°C
for 15 min (SEF-A); and (iii) filtration with a 300,000-
molecular-weight cutoff filter (Amicon Corp., Lexington,
Mass.). The filtrate was designated SEF-F (0.20 mg [dry
weight]/ml for strain P-2383 and 0.25 mg/ml for strain P-1062)
and utilized directly. The retentate was washed three times
on the filtration membrane with PBS and designated as SEF-
R (0.94 mg [dry weight]/ml for strain P-2383 and 0.80 mg/ml
for strain P-1062). Control hyaluronic acid (human umbilical
cord) (Sigma) and hyaluronidase (Sigma) at a concentration
of 1 mg/ml in PBS were prepared. The SEF-R of strain P-
2383 was treated with bovine testicular hyaluronidase (1 mg
of hyaluronidase per mg [dry weight] of SEF-R of strain P-
2383) (Sigma) and then filtered with a 300,000-molecular-
weight cutoff filter (Amicon). The filtrate was designated
SEF-RH-F (0.80 mg [dry weight]/ml for strain P-2383 and
0.62 mg/ml for strain P-1062) and utilized directly. The
retentate was washed three times as previously described
and designated SEF-RH-R (1.4 mg [dry weight]/ml for strain
P-2383 and 0.98 mg/ml for strain P-1062).
PMN preparation. PMNs were isolated as previously
described (23). Briefly, peripheral blood from healthy adult
cattle was collected in acid-citrate-dextrose solution and
centrifuged, and the plasma and buffy coat layer were
discarded. Erythrocytes in the packed-cell fraction were
lysed with distilled water, and the remaining cells, which
generally consisted of greater than 90% granulocytes, were
washed and suspended in PBS to a concentration of 5.0 x
107 PMNs/ml. The cells were held at room temperature and
were used in all three PMN function tests.
PMN function tests. The procedures for evaluating PMN
functions have been described in detail before (23). All PMN
function tests were conducted in duplicate, and the average
of duplicate values was used for calculation.
(i) Staphylococcus aureus ingestion. Heat-killed [t25I]iodo-
deoxyuridine ([1251]UdR, Amersham Corp., Arlington
Heights, Ill.)-labeled S. aureus was used to evaluate inges-
tion by PMNs. The test was conducted in plastic tubes (12 by
75 mm), and the standard reaction mixture contained 0.1 ml
of [125 ]UdR-labeled S. aureus, 0.05 ml of PMNs (2.5 x 106
PMNs, bacteria-to-PMN ratio = 60:1), 0.05 ml of a 1:10
dilution of bovine anti-S. aureus serum, and 0.3 ml of Earle
balanced salt solution (EBSS, GIBCO, Grand Island, N.Y.).
To determine the effect of bacterial fractions on ingestion by
PMNs, 0.05 ml of a P. multocida fraction (5.0 x 108 cells or
equivalent solution) or 0.05 ml of PBS as a control was added
to the standard reaction mixture. The reaction was allowed
to proceed for 10 min at 37°C, and the extracellular S. aureus
was removed by lysostaphin (Sigma) treatment. The PMNs
were washed by centrifugation, and the amount of PMN-
associated radioactivity was determined. The results were
expressed as the percentage of [1251]UdR-labeled S. aureus
that was ingested.
(ii) NBT reduction. This test was conducted in silicon-
coated glass tubes (15 by 100 mm), and the standard reaction
mixture contained 0.2 ml of nitroblue tetrazolium (NBT)
solution (2 mg/ml), 5.0 x 106 PMNs, 0.1 ml of preopsonized
zymosan preparation (10 mg/ml), and 0.6 ml of EBSS. To
determine the effect of bacterial fractions on NBT reduction
by PMNs, 0.1 ml of a P. multocida fraction (109 cells or
equivalent solution) or 0.1 ml of PBS as a control was added
to the standard reaction mixture. After 10 min of incubation
at 37°C, the reaction was stopped. The purple formazan
formed by the reduction of NBT was extracted with pyri-
dine, and the OD at 580 nm was determined. The results are
expressed as OD per 5.0 x 106 PMNs per 10 min in 5.0 ml of
pyridine.
(iii) lodination. The iodination test was conducted in
polystyrene snap-cap tubes (12 by 75 mm) (model 2058,
Falcon, Oxnard, Calif.). The standard reaction mixture
contained 2.5 x 106 PMNs, 0.05 ,Ci of 1251 (Carrier Free,
Amersham Corp., Arlington Heights, Ill.), 40 nmol of Nal,
0.05 ml of opsonized zymosan (10 mg/ml), and 0.3 ml of
EBSS. To determine the effect of bacterial fractions on
iodination by PMNs, 0.05 ml of P. multocida fraction (5.0 x
108 cells or equivalent solution) or 0.05 ml of PBS as a
control was added to the standard reaction mixture. The
reaction was allowed to proceed for 20 min at 37°C, and the
amount of trichloroacetic acid-precipitable radioactivity was
determined. The results are expressed as nanomoles of Nal
per 107 PMNs per hour.
Data analysis of PMN function test. To determine the effect
of bacterial fractions on each PMN function, the value
f
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68 RYU ET AL.
obtained when a bacterial fraction was added to the PMNs
was compared with the value obtained with control (PBS-
treated) PMNs. An analysis-of-variance procedure was used
to determine significance of the differences in PMN function.
For the graphic presentation of the data, all treatment values
were expressed as a percentage of the control.
Chemical analysis of bacterial fractions. Total carbohy-
drate was determined with a phenol-sulfuric acid procedure
(11), using glucose as a standard. Hyaluronic acid was
determined by the reaction of hexuronic acid with carba-
zole (Sigma) and H2SO4 (10), using D-glucuronic acid (Sig-
ma) as a standard. Protein content was determined colori-
metrically from the reaction of protein with Serva blue G dye
(Serva fine Chemicals, Inc., Long Island, N.Y.), using
bovine serum albumin (Sigma) as a standard (21).
Xanthine-xanthine oxidase-horseradish peroxidase-mediat-
ed iodination. A chemical iodination procedure was formu-
lated by following the basic principle ofPMN iodination (15,
22). Xanthine (Sigma) was used as a substrate, and xanthine
oxidase (Sigma) served as the enzyme for the production of
superoxide anion. Horseradish peroxidase (Sigma) was used
to catalyze the iodination reaction. The standard mixture
contained 40 nmol of Nal, 0.05 p.Ci of 1251, 0.3 ml of EBSS
containing 0.1% bovine serum albumin, 0.5 mg of xanthine,
0.5 U of horseradish peroxidase, and 0.05 ml of SEF or PBS
as a control. The reaction was started by the addition of 0.02
U of xanthine oxidase. The mixture was incubated and
processed by the same procedures as that used for PMN
iodination. A blank containing all components except xan-
thine oxidase was run with each experiment. Results are
expressed in counts per minute.
RESULTS
Effect of P. multocida fractions on S. aureus ingestion. To
determine the effect of P. multocida fractions on phagocytic
activity, PMNs were added to a standard suspension of
opsonized S. aureus in the presence or absence of P.
multocida fractions. Control PMNs ingested 28.6 ± 2.3%
(mean ± standard error) (n = 22) of the S. aiureus in the
100-
_
0
Strain P-2383
Strain P.1062
80
70
~60
o 0
~5O
40
30
20-
10
LCF KCF DCF SEF
FIG. 2. Effect of type A P. multocida fractions on S. aiureus
ingestion by bovine PMNs. Values represent mean percentages
(±standard deviation) of the control value. Statistically significant
differences from the control value are as indicated: **, P < 0.01; n =
16 for the SEF and n = 6 for all other fractions.
110
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FIG. 3. Characterization of the inhibitory activity in the SEF on
S. aureus ingestion by bovine PMNs. Values represent mean
percentages (±standard deviation) of the control value. Statistically
significant differences from the control value are as indicated: **,
P < 0.01; n = 6 for all fractions.
reaction mixture. In the presence of LCF, KCF, and SEF of
the two strains of P. multocida, S. aureus ingestion was
inhibited by 42 to 51% (Fig. 2). DCF had no effect on S.
aureus ingestion by PMNs. To further characterize the
inhibitory factor, SEF was treated with hyaluronidase, auto-
claved, or filtered through a 300,000-molecular-weight cutoff
filter. Neither autoclaving nor treatment with hyaluronidase
destroyed the inhibitory activity of SEF on S. aureus
ingestion by PMNs (Fig. 3). SEF-R did inhibit S. aureus
ingestion by PMNs by 41 to 60%, but SEF-F had no effect on
the PMN ability to ingest S. aureus. In a separate experi-
ment to further characterize SEF-R of strain P-2383, the
control PMNs ingested 36.1 ± 1.4% (mean ± standard error)
(n = 8) of the S. aureus in the reaction mixture. SEF-RH-R
inhibited S. aureus ingestion by PMNs by 59%, but SEF-
RH-F had no effect on the PMNs ability to ingest S. aureus
(see Fig. 7). S. aureus ingestion by PMNs was not inhibited
by either hyaluronic acid or hyaluronidase. To determine
whether the inhibitory substance was binding to the S.
aureus or the PMNs, the S. aureus ingestion assay was
performed by using S. aureus and PMNs which had been
separately treated with strain P-2383 SEF-RH-R by incuba-
tion for 20 min at 37°C in a shaking water bath and then
washed three times with PBS. The results (Table 1) indicate
that the inhibitory substance was removed by washing and
did not bind to either the PMNs or the S. aureus.
Effect of P. multocida fractions on NBT reduction. To study
the effect of P. multocida fractions on oxidative metabolism
of PMNs, the ability of PMNs to reduce NBT by the
production of superoxide anion in the presence or absence of
the bacterial fractions was determined. NBT reduction by
control PMNs was 0.47 ± 0.01 OD at 580 nm (mean ±
standard error) (n = 15). None of the fractions of the two
type A strains significantly (P > 0.05) affected NBT reduc-
tion by PMNs (Fig. 4).
Effect of P. multocida fractions on iodination. To study the
effect of P. minlto(ida fractions on the myeloperoxidase-
H2O,-halide antibacterial system of the PMNs, the ability of
PMNs to iodinate protein in the presence or absence of the
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P. MULTOCIDA EFFECTS ON PMNs 69
TABLE 1. Effect of preincubation of PMNs and S. aureius with
strain P-2383 SEF-RH-R on the ingestion of S. alureius by PMNs
% ingested S. aureius" in bacterial
Pretreatment (followed fraction added to reaction mixture:
by washing)
None SEF-RH-R
None 29.8 ± 3.3 19.9 ± 1.8
S. aureus preincubated 27.1 ± 2.1 17.6 ± 2.4
with SEF-RH-R
PMNs preincubated 31.8 ± 4.4 21.2 ± 4.8
with SEF-RH-R
Both S. aureus and 29.8 ± 3.1 23.4 ± 2.4
PMNs preincubated
with SEF-RH-R
a Mean ± standard error (n = 6).
bacterial fractions was determined. The value for iodination
by control PMNs was 42.3 + 2.2 nmol of Nal per 107 PMNs
per h (mean ± standard error) (n = 22). The ability of PMNs
to iodinate protein in the presence of LCF, KCF, and SEF of
the two strains was inhibited 30 to 36%, but DCF had no
effect on iodination by PMNs (Fig. 5). When SEF was
processed for further characterization of the inhibitory fac-
tor as described for the S. aureus ingestion assay, neither
autoclaving nor treatment with hyaluronidase destroyed the
inhibitory activity of SEF on iodination by PMNs (Fig. 6).
SEF-R inhibited iodination by PMNs by 35 to 49%, and
SEF-F did not. In a separate experiment to further charac-
terize SEF-R of strain P-2383, the value for iodination by
control PMNs was 37.8 ± 1.6 nmol of Nal per 107 PMNs per
h (mean ± standard error) (n = 8). SEF-RH-R inhibited
iodination by 70%, and SEF-RH-F had no effect (Fig. 7).
lodination by PMNs was not inhibited by either hyaluronic
acid or hyaluronidase.
Titration of the inhibitory activity of the bacterial fraction.
Strain P-2383 SEF was used to evaluate the concentration
effect of the bacterial fraction on S. aureus ingestion and
iodination by PMNs. The inhibitory activities were concen-
tration dependent, but neither was completely inhibited even
at the highest concentration of the bacterial fraction (Fig. 8).
Strain P-2383
Strain P-1062
100
90
80s-
70-
I60
LCF KCF DCF SEF
FIG. 4. Effect of type A P. multocida fractions on NBT reduc-
tion by bovine PMNs stimulated with opsonized zymosan. Values
represent mean percentages (+standard deviation) (n = 6) of the
control value. None of the differences was statistically significant
(P > 0.05).
Strain P-2383
Strain P-1062
570
50
LCF KCF DCF SEF
FIG. 5. Effect of type A P. multocida fractions on iodination by
bovine PMNs stimulated with opsonized zymosan. Values represent
mean percentages (± standard deviation) of the control value. Statis-
tically significant differences from the control values are as indicat-
ed: **, P< 0.01; *, 0.01 <P < 0.05; n = 16 for SEF and n = 6 for all
other fractions.
Chemical analysis. The results of chemical analysis of the
bacterial fractions are shown in Table 2.
Effect of the saline-extracted capsule on xanthine-xanthine
oxidase-horseradish peroxidase-mediated iodination. To fur-
ther study the effect of SEF on the iodination reaction, a
chemically mediated iodination reaction was used which did
not involve PMNs. Xanthine and xanthine oxidase were
used to generate superoxide anion, which spontaneously
forms H202. Horseradish peroxidase was used to catalyze
the hydrogen peroxide-halide reaction. SEF did not inhibit
the xanthine-xanthine oxidase-horseradish peroxidase iodin-
ation system (Table 3).
100 Strain P-2383100_
Strain P-1062
90
80
~70-
060
I
SEF-A SEF-H SEF-R SEF-F
FIG. 6. Characterization of the inhibitory activity of the SEF on
iodination by bovine PMNs. Values represent mean percentages
(+standard deviation) (n = 6) of the control value. Statistically
significant differences from the control value are as indicated: **,
P < 0.01; *, 0.01 < P < 0.05.
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£S. aureus ingestion
Ism lodination
TABLE 2. Chemical analysis of strain P-2383 bacterial fractions
Concn Carbohydrate Hyaluronic ProteinFraction (mg [dry (mg/ml) acid(mgweight]/ml) (mg/ml)
SEF 1.06 0.38 0.17 0.07
SEF-R 0.94 0.33 0.17 0.06
SEF-RH-R 1.40 0.35 0.12 0.25
SEF-RH-F 0.80 0.26 0.04 0.22
Is
SEF-RH-R SEF-RH-F Hyaluronic Acid Hyaluronidm
FIG. 7. Characterization of the inhibitory activity of the SEF of
strain P-2383 on S. aureus ingestion and iodination by bovine
PMNs. Values represent mean percentages (±standard deviation) of
the control value. Statistically significant differences from the
control value are as indicated: **, P < 0.01; n = 8 for all fractions.
DISCUSSION
PMNs are important in protecting animals from microbial
infection by their phagocytic activities. According to Root
and Cohen (22), two major microbicidal events occur inside
a PMN when a microorganism is ingested: (i) the generation
of highly toxic products of oxygen by the oxidative metabo-
lism, and (ii) the enzymatic destruction and digestion of the
microorganism by the lysosomal enzymes present in the
intracellular granules which fuse with the phagocytic vacu-
oles. However, many pathogenic microorganisms have de-
veloped mehanisms to inhibit phagocytic cell activity to
facilitate their survival in the host (9).
The ingestion of bacteria is the first step in the bactericidal
activity of the PMN. The results of the S. aureus ingestion
assay indicate that the capsule of type A P. multocida
-6
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inhibits the ability of PMNs to ingest particles. When
bacterial fractions containing whole organisms were used,
the inhibition of ingestion of S. aureus may have been due to
competition between the two bacterial species. However,
when soluble bacterial fractions were used competition for
ingestion should not have been a factor. In addition, the
results shown in Table 1 indicate that the inhibitory activity
was not retained after washing of pretreated PMNs or
bacteria. Apparently, this substance has an effect on PMN
metabolism which is reversible and is not mediated through
binding to a high-affinity receptor. The mechanism of action
of this material is not known and is the subject of further
investigation. Maheswaran and Thies (18) reported that
removal of -the capsule from type A P. multocida (the same
capsular type used in this experimentation) with hyaluroni-
dase enabled PMNs to ingest the decapsulated organisms.
Maheswaran and Thies speculated that the inhibitory sub-
stance was hyaluronic acid. The results reported here,
however, indicate that hyaluronic acid per se is not responsi-
ble for the inhibition of PMN function. Hyaluronic acid
isolated from human umbilical cord did not suppress PMN
function. Thus, the repeating disaccharide (D-glucuronic
acid and N-acetyl-D-glucosamine) backbone structure of
hyaluronic acid, which would be common between the
hyaluronic acids of human and bacterial origins, was not
responsible for the inhibition ofPMN function. It is possible
that the PMN inhibitory substance is structurally linked to
the bacterial hyaluronic acid. The treatment of the capsular
material with hyaluronidase did not destroy the inhibitory
factor. The hyaluronidase treatment did destroy the mucoid
viscous nature of the SEF. Even after hyaluronidase treat-
ment, there was still some glucuronic acid (a component of
hyaluronic acid) which did not pass through the 300,000-
molecular-weight cutoff membrane. Since hyaluronic acid of
the P. multocida capsule serves as a framework for other
molecules (3), there may be a variety of chemical compo-
nents attached to hyaluronic acid which would not be
degraded by the hyaluronidase. These molecules may be
large enough to retain associated glucuronic acid from
passing through the 300,000-molecular-weight cutoff mem-
brane. The hyaluronic acid fragments which did pass
through the membrane (SEF-RH-F) did not inhibit PMN
function.
TABLE 3. Effect of SEF of type A P. multocida on xanthine-
xanthine oxidase-horseradish peroxidase-mediated iodination
Bacterial fraction vodination
value (cpm)"
Blank (no xanthine oxidase) ........ ............... 245 ± 18
J Control (PBS).............. 1,466 ± 129
4 SEF of strain P-2383 .............. 1,453 ± 78
SEF of strain P-1062 .............. 1,502 ± 89
a Mean ± standard error of eight experiments. The differences
from the control value are not statistically significant (P > 0.05).
0 0.5 1 2 3
mg/ml Dry Weight
FIG. 8. Effect of various concentrations of strain P-2383 SEF
S. aureus ingestion and iodination by PMNs (n = 6).
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Oxidative metabolism of the PMN is an important aspect
of its bactericidal activity (22). When a PMN receives the
proper stimulus, an oxidase enzyme on the surface of the
plasma membrane or phagosomal membrane will catalyze
the conversion of oxygen to superoxide anion. Superoxide
anion spontaneously dismutates to hydrogen peroxide. NBT
is directly reduced by the superoxide anion to an insoluble
purple formazan (26). NBT reduction is therefore a measure
of superoxide anion generation by the PMN. Since NBT
reduction was not inhibited by whole bacteria or bacterial
fractions (Fig. 4), type A P. mnultocida apparently does not
inhibit the production of superoxide anion by PMNs.
The iodination reaction is a measure of the ability of
PMNs to convert inorganic iodide to a trichloroacetic acid-
precipitable (protein-bound) form and occurs inside the
phagocytic vacuole via the action of hydrogen peroxide and
myeloperoxidase. This system has been found to exhibit a
marked toxic activity toward bacteria, fungi, and viruses (1,
24). The iodination reaction by PMNs is dependent upon the
generation of hydrogen peroxide, degranulation to release
myeloperoxidase, the presence of iodine, the unimpaired
ability of myeloperoxidase to catalyze the reaction, and the
presence of tyrosine to bind iodine. Hydrogen peroxide is
formed spontaneously from superoxide anion. Since SEF
did not inhibit NBT reduction, superoxide anion generation
by PMNs is apparently not affected by the inhibitory factor.
Since the xanthine-xanthine oxidase-horseradish peroxi-
dase-mediated iodination was not inhibited by SEF, the rate
of formation of hydrogen peroxide from superoxide anion
and the rate of hydrogen peroxide destruction were appar-
ently not affected. In addition, the ability of the peroxidase
enzyme to catalyze the reaction was apparently not im-
paired. It must be kept in mind that horseradish peroxidase
and myeloperoxidase are different enzymes. It is possible
that the inhibitory factor could inhibit myeloperoxidase
directly without inhibiting horseradish peroxidase, but this
does not seem likely.
This experimentation demonstrated that phagocytosis and
protein iodination by PMNs were inhibited in the presence of
whole P. inultocida organisms and bacterial fractions. Since
the removal of the capsule removed the inhibitory capability,
the inhibitory activity apparently resides in the capsule or
surface structure of the bacterial cell. The inhibitory factor is
a heat-stable, saline (2.5%, wt/vol)-extractable capsular ma-
terial of greater than 300,000 molecular weight. The inhibi-
tory activity cannot be attributed to hyaluronic acid, but it
may be structurally associated with it.
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